BRIDGEBIO PHARMA INC

CUSIP: 10806XAD4 Class: Convertible Debt

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 2,000,000 Value ($000) $1,975 Avg Close — Range —
Q2 2025
Shares 2,000,000 Value ($000) $1,873 Avg Close — Range —
Q1 2025
Shares 2,000,000 Value ($000) $1,798 Avg Close — Range —
Q4 2024
Shares 2,000,000 Value ($000) $1,709 Avg Close — Range —
Q3 2024
Shares 1,500,000 Value ($000) $1,253 Avg Close — Range —
Q2 2024
Shares 1,500,000 Value ($000) $1,209 Avg Close — Range —
Q1 2024
Shares 1,500,000 Value ($000) $1,234 Avg Close — Range —
Q4 2023
Shares 1,500,000 Value ($000) $1,268 Avg Close — Range —
Q3 2023
Shares 1,500,000 Value ($000) $1,139 Avg Close — Range —
Q2 2023
Shares 1,500,000 Value ($000) $923 Avg Close — Range —
Q1 2023
Shares 1,500,000 Value ($000) $956 Avg Close — Range —
Q4 2022
Shares 3,000,000 Value ($000) $1,155 Avg Close — Range —
Q3 2022
Shares 3,000,000 Value ($000) $1,331 Avg Close — Range —
Q2 2022
Shares 3,000,000 Value ($000) $1,263 Avg Close — Range —
Q1 2022
Shares 3,000,000 Value ($000) $1,429 Avg Close — Range —